Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 Study

Taneja Samir S.

首页> 外文期刊>The Journal of Urology >Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 Study

【24h】

Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 Study

机译：Re：烯醇酰胺酰胺与甲磺丁胺的疗效和安全性，用于转移前列腺癌（地形）：随机，双盲，第2期研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2017年第1期|共1页
作者
Taneja Samir S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 Study [J] . Taneja Samir S. The Journal of Urology . 2017,第1期

机译：Re：烯醇酰胺酰胺与甲磺丁胺的疗效和安全性，用于转移前列腺癌（地形）：随机，双盲，第2期研究
2. Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial [J] . Siemens D. Robert, Klotz Laurence, Heidenreich Axel, The Journal of Urology . 2018,第1期

机译：苯甲甲酰胺与Bicalutamide在地形试验中的抗转移阉割前列腺癌的患者中的疗效和安全性
3. Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial [J] . Heidenreich Axel, Chowdhury Simon, Klotz Laurence, European urology . 2017,第4期

机译：与基辛酰胺对苯甲酰胺的影响与基于转移性阉割前列腺癌的男性的生活质量：地形随机临床试验的额外分析
4. Identification of Circulating Pluripotent Cancer Stem Cells in the Blood of Prostate Cancer Patients for the Diagnosis of Metastatic Cancer [C] . Anette Claudia Schafer, Yawen Ju, Youngbin Tak, International Molecular Medicine Tri-Conference. . 2016

机译：鉴定前列腺癌患者血液中循环多能癌症干细胞诊断转移性癌症
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study) [O] . Taro Iguchi, Satoshi Tamada, Minoru Kato, 2019

机译：恩杂鲁胺与氟他胺治疗比卡鲁胺联合雄激素阻断治疗后去势抵抗性前列腺癌：一项多中心随机II期试验的研究方案（OCUU-CRPC研究）
7. Bicalutamide ('Casodex') 150mg in addition to standard care in patients with nonmetastatic prostate cancer: Updated results from a randomised double-blind phase III study (median follow-up 5.1y) in the early prostate cancer programme [O] . Wirth M., Tyrrell C., Delaere K., 2005

机译：比卡鲁胺（'Casodex'）150mg，对非转移性前列腺癌患者的标准治疗：早期前列腺癌计划的随机双盲III期研究（中位随访5.1y）的最新结果

Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 Study

著录项

相似文献

相关主题

期刊订阅